Sharing Knowledge

Sonrai Case Studies

Subscribe to stay up to date with the latest Sonrai content.

The Difference Sonrai Makes

We aim for perfection for our customers. We listen, quickly grasp the challenges, consider the needs of all stakeholders, and then deliver world-class solutions. Our guiding light is to improve diagnosis and treatment for patients worldwide. Check out some of our case studies to understand how we can help.

Patient Stratification
50% Reduction in Adverse Events

Our client saw a 50% reduction in adverse events during phase I trials through AI-driven patient stratification, leveraging integrated multi-modal data for more personalized treatments.

Target Identification and Validation
330 % ROI over 24 months
Biomarker Discovery

What would a 40% reduction in the validation cost per target mean to your organisation? Discover how Sonrai empowered a pharmaceutical company to identify, validate, and confirm therapeutic protein targets for precision medicine. Explore the full case study for insights into innovative drug development.

Unified Code and No-Code Discovery
42% Faster Time to Initial Data Analysis
Biomarker Discovery

See how Sonrai united code and no-code scientists in one code-optional analysis environment, reducing turnaround times by 2 weeks.

Accelerating MoA Studies
41% Reduction In-House Computational Infrastructure
Biomarker Discovery

Sonrai's cloud-based advanced analytics accelerated our clients MoA studies by 57% and reduced their in-house computational infrastructure by 41%.

AI IVDR Medical Devices
Biomarker Discovery

Sonrai is developing a suite of transformational IVD medical devices using AI-powered computational pathology to aid pathologists.

Predictive Biomarker Discovery
52% Faster Biomarker Discovery
Biomarker Discovery

Sonrai's integrated biomarker discovery toolkit boosted our client's biomarker discovery by 52%, enabling them to begin clinical trials 24% faster.

Biomarker Discovery
Biomarker Discovery

See how we enabled GenoMe Diagnostics to scientifically and reproducibly shortlist novel potential biomarkers and take forward the most promising.

Diagnostic Validation

Enabled IVBH's precision diagnostics by unlocking data insights, accelerating development.

Preclinical Data Management

Enhanced data visualisation, interactive reports and increased data accuracy & validation.

Imagine What You Could Discover

Our cloud-based AI technology unifies and integrates all data sources from discovery, research, and development to regulatory approval.
Multi-Modal Biomarker Discovery
Biomarker Discovery

Discover how Sonrai's integration of genomic, proteomic, imaging, and clinical data accelerated multi-modal biomarker discovery.

Future Proof Cloud Drug Discovery
Biomarker Discovery

Discover how our client achieved unparalleled scalability and accessibility by migrating their analysis applications to the Sonrai Discovery cloud platform.

Optimizing Clinical Trial Data

Discover how a pharma company overcame data challenges in Phase II trials with Sonrai's AI-driven analytics and precision medicine tools.

Integrating Imaging and Omic Data
Biomarker Discovery

Explore how Sonrai's advanced analytics can help companies overcome challenges in drug development by integrating imaging and omic data.

Enhancing Invivo Drug Efficacy
14% Reduction in Preclinical Phase
Biomarker Discovery

Sonrai supported a pharma client by integrating multi-modal data. The company reduced their preclinical phase by 14% and decreased their manual labor required for data processing by 62%.

Multi-Omic Drug Discovery
13 Months Time-to-Market Acceleration

Our client saw a reduction from 6 months to 5 weeks in their analysis time. Sonrai's streamlined processes and integrated analytics accelerated time-to-market by over a year.

Multi-Modal Drug Discovery

Explore how Sonrai helps companies accelerate drug development by overcoming challenges in multi-modal data integration.

Immunotherapy Development - A Bench - Bedside Case Study
50% Time Reduction in Antibody Discovery Process
Biomarker Discovery

We helped our client reduce R&D time by 50% by analyzing preclinical, translational and clinical data in one centralized location.

AI-Powered Single-Cell Analysis & Automated Cell Annotations
Biomarker Discovery

Explore how AI can enhance single-cell analysis by faster data processing to accelerate findings and drug development.

AI-Enabled High Content Screening

Uncover intricate molecular pathways, optimize drug designs, and accelerate mechanism of action studies, ultimately leading to more effective therapeutic interventions.

AI Patient Stratification Workflow
Biomarker Discovery

Discover AI patient stratification in drug development - interactive visualizations, multimodal data integration, and transparent ML insights.

Federated Cloud Infrastructure for Science Park and Collaborative Labs
Biomarker Discovery

Discover how Sonrai Analytics empowers research and collaboration with the innovative AI platform for data management and discovery.

AI Biomarker Discovery Workflow
Biomarker Discovery

Explore an end-to-end AI biomarker discovery workflow using Sonrai Discovery. Discover just how easy it can be.

Advanced Data Management and Analytics in Clinical Trials
Biomarker Discovery

Explore advanced data management and analytics in clinical trials with a synthetic Phase I trial of Tyzolimab for Advanced Esophageal Squamous Cell Carcinoma (ESCC).

Biomarker Discovery using Flow Cytometry Data
Biomarker Discovery

Explore the cutting-edge world of biomarker discovery using flow cytometry data with Sonrai Discovery technology.

End-To-End Bulk RNA-Seq Analysis
Biomarker Discovery

Explore the power of bulk RNA-Seq analysis with our end-to-end workflow using the NextFlow RNA-Seq pipeline and Sonrai Discovery.

Automatic Public Data Pulling and Processing using Bioinformatic Pipelines
Biomarker Discovery

Discover how Sonrai's bioinformatic pipelines automate public data pulling and processing, particularly focused on RNA-Seq data.